- Home
- PESI vs ACHV Comparison
PESI vs ACHV Comparison
Compare PESI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- ACHV
- Stock Information
- Founded
- PESI 1990
- ACHV N/A
- Country
- PESI United States
- ACHV Canada
- Employees
- PESI N/A
- ACHV N/A
- Industry
- PESI Environmental Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PESI Industrials
- ACHV Health Care
- Exchange
- PESI Nasdaq
- ACHV Nasdaq
- Market Cap
- PESI 153.6M
- ACHV 159.0M
- IPO Year
- PESI 1992
- ACHV N/A
- Fundamental
- Price
- PESI $10.92
- ACHV $4.47
- Analyst Decision
- PESI Strong Buy
- ACHV Strong Buy
- Analyst Count
- PESI 1
- ACHV 3
- Target Price
- PESI $18.00
- ACHV $14.00
- AVG Volume (30 Days)
- PESI 80.7K
- ACHV 85.7K
- Earning Date
- PESI 10-31-2024
- ACHV 11-07-2024
- Dividend Yield
- PESI N/A
- ACHV N/A
- EPS Growth
- PESI N/A
- ACHV N/A
- EPS
- PESI N/A
- ACHV N/A
- Revenue
- PESI $72,199,000.00
- ACHV N/A
- Revenue This Year
- PESI N/A
- ACHV N/A
- Revenue Next Year
- PESI $52.51
- ACHV N/A
- P/E Ratio
- PESI N/A
- ACHV N/A
- Revenue Growth
- PESI N/A
- ACHV N/A
- 52 Week Low
- PESI $6.51
- ACHV $3.03
- 52 Week High
- PESI $14.17
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- PESI 52.26
- ACHV 50.71
- Support Level
- PESI $9.58
- ACHV $4.23
- Resistance Level
- PESI $10.94
- ACHV $4.33
- Average True Range (ATR)
- PESI 0.50
- ACHV 0.15
- MACD
- PESI 0.04
- ACHV 0.02
- Stochastic Oscillator
- PESI 61.90
- ACHV 53.13
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: Treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.